ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2022, Vol. 31 ›› Issue (6): 579-584.DOI: 10.3969/j.issn.1006-298X.2022.06.016

• • 上一篇    下一篇

抗血管紧张素Ⅱ1型受体抗体在肾脏疾病中的应用

  

  • 出版日期:2022-12-28 发布日期:2023-01-04

Application of angiotensin Ⅱ type 1 receptor autoantibodies in renal diseases

  • Online:2022-12-28 Published:2023-01-04

摘要: 在免疫性肾脏疾病及器官移植体液性排异反应中,自身抗体发挥非常重要作用,特异性自身抗体不仅作为相关疾病诊断的标志物,也常常作为治疗的靶点。抗血管紧张素Ⅱ1型受体(AT1R)抗体是近年发现与肾移植体液性排斥反应、自身免疫性疾病、系统性硬化相关肺动脉高压以及心血管疾病发生密切相关的一种新的自身抗体,在肾移植以外肾脏疾病的临床意义缺乏研究。本文将介绍抗AT1R抗体的产生及危险因素、潜在的致病机制以及在肾脏疾病中的应用,为肾脏疾病诊治提供新思路。


关键词: 抗血管紧张素Ⅱ1型受体抗体, 狼疮性肾炎, 糖尿病肾病

Abstract: Autoantibodies play a very important role in development of immune kidney diseases and organ transplant humoral rejection. Specific autoantibodies are often used not only as markers for diagnosis of related diseases, but also as targets for treatment. The antiangiotensin Ⅱ type 1 receptor antibody (AT1R) is a new autoantibody that has been found to be closely associated with renal transplant humoral rejection, autoimmune diseases, systemic sclerosisassociated pulmonary arterial hypertension, and development of cardiovascular diseases in recent years. Its clinical significance in renal diseases other than renal transplantation is lacking in research. This article introduces production and risk factors of antiAT1R, possible pathogenic mechanisms, its application and treatment in transplant rejection and renal diseases, providing new ideas for diagnosis and treatment of renal diseases.


Key words: anti-angiotensin Ⅱ type 1 receptor antibody, lupus nephritis, diabetic nephropathy